Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Ex-Kite execs form a CAR T rival

April 4, 2018 Research and Development, Sales and Marketing Allogene, Pfizer, biotech, drugs, pharma, pharmaceutical

After working to bring through Kite Pharma from the pre-clinical development stage to its final $12 billion acquisition by Gilead, …
News

Patient experience: Living with ovarian cancer

April 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ingrid Copperman, feature, ovarian cancer, patient experience, pharma

Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social …
Feature

One centre for cancer diagnoses trialled

April 3, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS England is trialling centres that should be able to provide rapid answers as to whether a patient has cancer …
News

Alkermes sent reeling as FDA refuses review of depression treatment

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Alkermes, FDA, depression, major depressive disorder, pharma

Alkermes shares were knocked down to their lowest level since October 2016 after it was revealed that the FDA had …
News

Rumours Allergan is looking to offload $5bn women’s health unit

April 3, 2018 Manufacturing and Production, Sales and Marketing Allergan, Restasis, biotech, drugs, pharma, pharmaceutical

According to a piece by Bloomberg, Allergan is looking at options to divest its women’s health unit in a move …
News

AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma

AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …
News

Celgene’s COO heads to the exit

April 3, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Celgene, Mark Alles, Scott Smith, biotech, drugs, pharma, pharmaceutical

Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …
News

Top Ten most popular articles on Pharmafile.com this week

March 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten

As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …
News

bluebird backs own CAR-T prospect, takes option to co-develop with Celgene

March 29, 2018 Sales and Marketing Bluebird Bio, CAR T, CAR-T, Celgene, biotech, drugs, pharma, pharmaceutical

Biotech companies showing faith in their own prospect drug candidates is not an unusual occurrence, some do it to extremes. …
News

Teva spared payout to GSK over patent infringement dispute

March 29, 2018 Sales and Marketing Coreg, GSK, GlaxoSmithKline, Teva, carvedilol, heart failure, pharma

Teva has been spared a sizeable payout to GlaxoSmithKline after a federal judge overturned a US jury verdict demanding that …
News

Fujifilm bolsters healthcare with two biotech buys for $800m

March 29, 2018 Sales and Marketing Fujifilm, biotech, drugs, pharma, pharmaceutical

Fujifilm has made no secret of the fact it is looking to switch up part of its core business to …
News

Takeda moots Shire move but big questions remain

March 28, 2018 Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

Takeda is considering making a bold move for Shire, after announcing, as per UK regulations, that it may make an …
News

InSight Innovations to buy CureTech in $550m deal

March 28, 2018 Research and Development, Sales and Marketing Cancer, CureTech, Insight Innovations, Pfizer, Teva, brain cancer, brain tumour, immunotherapy, israel

Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …
News

Brexit Health Alliance: Brexit and the impact on patient access to medicines

March 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma

On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …
Feature

Abbvie pays out over $3m after its testosterone replacement drug leads to heart attack

March 27, 2018 Manufacturing and Production, Sales and Marketing AbbVie, Endo, GSK, androgel, heart attack, pharma

Abbvie has been ordered to pay over $3 million in damages to a man who asserts that the uise of …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026